Crossmark

Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension

Crossref DOI link: https://doi.org/10.1186/s13071-025-06797-w

Published Online: 2025-05-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jones, Sloane

Briantais, Philippe

Von Simson, Cristiano

De Meyrignac, Eleonore

Poincelot, Laure

Rigaut, Delphine
Funding

Funding for this research was provided by:

Virbac
License Information

Text and Data Mining valid from 2025-05-12

Version of Record valid from 2025-05-12
More Information

Article History

Received: 30 January 2025

Accepted: 11 April 2025

First Online: 12 May 2025

Declarations

:

: The study was approved by Virbac’s animal ethics committee according to Directive 2010/63/EU and the United States authorities’ requirements. Participation in this clinical trial was voluntary. Owners were fully informed about the trial's content and their rights. Signed informed consent was obtained from each dog owner.

: Not applicable.

: All authors were employed by Virbac.

Document is current

Any future updates will be listed below